Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 47

  • Filters activated: AIDS. Clear all to show 872 items.
1.

Understanding the inhibitory mechanism of BIT225 drug against p7 viroporin using computational study.

Behmard E, Abdolmaleki P, Taghdir M.

Biophys Chem. 2018 Feb;233:47-54. doi: 10.1016/j.bpc.2017.11.002. Epub 2017 Nov 16.

PMID:
29169687
2.

1,6-Bis[(benzyloxy)methyl]uracil derivatives-Novel antivirals with activity against HIV-1 and influenza H1N1 virus.

Geisman AN, Valuev-Elliston VT, Ozerov AA, Khandazhinskaya AL, Chizhov AO, Kochetkov SN, Pannecouque C, Naesens L, Seley-Radtke KL, Novikov MS.

Bioorg Med Chem. 2016 Jun 1;24(11):2476-85. doi: 10.1016/j.bmc.2016.04.010. Epub 2016 Apr 5.

PMID:
27112451
3.

Synthesis and Preliminary Antiviral Activities of Piperidine-substituted Purines against HIV and Influenza A/H1N1 Infections.

Kang D, Fang Z, Huang B, Zhang L, Liu H, Pannecouque C, Naesens L, De Clercq E, Zhan P, Liu X.

Chem Biol Drug Des. 2015 Oct;86(4):568-77. doi: 10.1111/cbdd.12520. Epub 2015 Feb 6.

PMID:
25600073
4.

Bacteria-based analysis of HIV-1 Vpu channel activity.

Taube R, Alhadeff R, Assa D, Krugliak M, Arkin IT.

PLoS One. 2014 Oct 1;9(10):e105387. doi: 10.1371/journal.pone.0105387. eCollection 2014.

5.

Arylazolyl(azinyl)thioacetanilide. Part 9: Synthesis and biological investigation of thiazolylthioacetamides derivatives as a novel class of potential antiviral agents.

Zhan P, Wang L, Liu H, Chen X, Li X, Jiang X, Zhang Q, Liu X, Pannecouque C, Naesens L, De Clercq E, Liu A, Du G.

Arch Pharm Res. 2012 Jun;35(6):975-86. doi: 10.1007/s12272-012-0604-y. Epub 2012 Jun 30.

PMID:
22870806
6.

Prophylactic and therapeutic combination effects of rimantadine and oseltamivir against influenza virus A (H3N2) infection in mice.

Simeonova L, Gegova G, Galabov AS.

Antiviral Res. 2012 Aug;95(2):172-81. doi: 10.1016/j.antiviral.2012.05.004. Epub 2012 May 19.

PMID:
22617756
7.

Antiviral activity of arbidol, a broad-spectrum drug for use against respiratory viruses, varies according to test conditions.

Brooks MJ, Burtseva EI, Ellery PJ, Marsh GA, Lew AM, Slepushkin AN, Crowe SM, Tannock GA.

J Med Virol. 2012 Jan;84(1):170-81. doi: 10.1002/jmv.22234. Epub 2011 Oct 25.

PMID:
22028179
8.

[Influenza : clinical symptoms, diagnostics and therapy].

Rohde GG.

Internist (Berl). 2011 Sep;52(9):1047-52. doi: 10.1007/s00108-011-2859-7. German.

PMID:
21809066
9.

Drug sensitivity, drug-resistant mutations, and structures of three conductance domains of viral porins.

Sharma M, Li C, Busath DD, Zhou HX, Cross TA.

Biochim Biophys Acta. 2011 Feb;1808(2):538-46. doi: 10.1016/j.bbamem.2010.07.015. Epub 2010 Jul 23. Review.

10.
11.

Influenza guideline for South Africa--update 2008.

Green RJ, Feldman C, Schoub B, Richards GA, Madhi SA, Zar HJ, Lalloo U; Guideline Committee of 1999, Klugman K, Phillips D, Cameron NA, Eggers RR.

S Afr Med J. 2008 Mar;98(3 Pt 2):224-30. Review.

PMID:
18652399
12.

Molecular strategies to inhibit the replication of RNA viruses.

Leyssen P, De Clercq E, Neyts J.

Antiviral Res. 2008 Apr;78(1):9-25. doi: 10.1016/j.antiviral.2008.01.004. Epub 2008 Feb 4. Review.

PMID:
18313769
14.

[Carboxy mimetic derivatives of nucleic acid polymeric backbones inhibiting human cytomegalovirus. 1. In vitro microbicidal effect].

Serbin AV, Karaseva EN, Fedorova NE, Pavlova MV, Klimova EV, Leont'eva MV, Kushch AA.

Antibiot Khimioter. 2007;52(11-12):8-13. Russian.

PMID:
19275050
15.

Synthesis, conformational characteristics and anti-influenza virus A activity of some 2-adamantylsubstituted azacycles.

Setaki D, Tataridis D, Stamatiou G, Kolocouris A, Foscolos GB, Fytas G, Kolocouris N, Padalko E, Neyts J, De Clercq E.

Bioorg Chem. 2006 Oct;34(5):248-73. Epub 2006 Aug 1.

PMID:
16879857
17.

Substitution of the transmembrane domain of Vpu in simian-human immunodeficiency virus (SHIVKU1bMC33) with that of M2 of influenza A results in a virus that is sensitive to inhibitors of the M2 ion channel and is pathogenic for pig-tailed macaques.

Hout DR, Gomez ML, Pacyniak E, Gomez LM, Fegley B, Mulcahy ER, Hill MS, Culley N, Pinson DM, Nothnick W, Powers MF, Wong SW, Stephens EB.

Virology. 2006 Jan 20;344(2):541-59. Epub 2005 Sep 30.

18.

Human infection by avian influenza A H5N1.

Yuen KY, Wong SS.

Hong Kong Med J. 2005 Jun;11(3):189-99. Review.

19.

In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds.

Chen F, Chan KH, Jiang Y, Kao RY, Lu HT, Fan KW, Cheng VC, Tsui WH, Hung IF, Lee TS, Guan Y, Peiris JS, Yuen KY.

J Clin Virol. 2004 Sep;31(1):69-75.

PMID:
15288617
20.

The influenza virus ion channel and maturation cofactor M2 is a cholesterol-binding protein.

Schroeder C, Heider H, Möncke-Buchner E, Lin TI.

Eur Biophys J. 2005 Feb;34(1):52-66. Epub 2004 Jun 25.

PMID:
15221235

Supplemental Content

Loading ...
Support Center